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Table 2. The laboratory ﬁndings of the study population
Group 1 Group 2 Group 3
p
Overall
p
Group
1-3
p
Group
2-3
p
Group
1-2
INR, % 2.54
(2.01-
2.99)
1.37
(0.94-
1.95)
0.97
(0.85-
1.21)
<0.001 <0.001 <0.001 <0.001
Hemoglobin,
g/dL
12.0
(11.0-
16.8)
12.0
(11.4-
16.3)
13.0
(11.7-
16.2)
0.193 - - -
WBC,
x1000/mL
7.34
(3.92-
11.3)
7.43
(3.91-
11.2)
7.12
(4.31-
11.0)
0.295 - - -
Platelet,
x1000/mL
236
(119-442)
219
(135-382)
236
(151-400)
0.173 - - -
MPV, fL 7.56
0.63
8.26
0.63
7.63
0.68
<0.001 0.710 <0.001 <0.001
PCT, % 0.174
(0.089-
0.274)
0.203
(0.106-
0.311)
0.183
(0.099-
0.304)
<0.001 0.433 <0.001 <0.001
PDW, % 17.3
(14.2-
19.4)
17.9
(13.7-
20.5)
17.5
(15.4-
19.7)
<0.001 0.165 0.004 <0.001
INR¼ International normalized ratio, MPV¼ Mean platelet volume, PCT¼ Plateletcrit, PDW¼
Platelet distribution width, WBC¼ White blood cell
Human platelet antigens -1 gene polymorphisms genotype and allel frequencies
AF patients
with stroke
(n:70)
Control
(n:65) P
n: % n: %
1a1a
genotype
49 70 57 87.7 0.012
1a1b
genotype
18 25.7 6 9.2 0.012
1b1b
genotype
3 4.3 1 1.5 0.347
1a1b + 1b1b
genotypes
(Dominant
genetic
model)
21 30 7 10.8 0.006
1b allel 24 17.1 8 6.1 0.009
P
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R
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Background: Atrial ﬁbrillation (AF) is the commonest sustained cardiac arrhythmia,
which confers a high risk of mortality and morbidity from stroke and thromboem-
bolism. Altered platelet activation and platelet-dependent thromboembolism have
been associated with the pathogenesis of cardiovascular or thromboembolic disorders,
which include atherosclerosis, coronary disease and cerebrovascular disease. Platelet
adhesion and activation are mediated by human platelet alloantigens (HPAs),
a complex of platelet membrane glycoproteins (Gp) and other cellbound Factors. By
altering platelet receptor sensitivity, polymorphisms in platelet Gp directly impact
platelet susceptibility to activating stimuli, which is linked with an increased risk of
atherothrombotic events, including acute myocardial infarction. We wanted to
investigate HPA-1 polymorphism in patients with AF who have had a stroke than in
healthy controls.
Methods: The HPA-1 polymorphism was analysed in 70 patients with nonvalvuler
AF who have had a stroke and 65 healthy individuals with no documented episode of
AF matched for age, race and sex. Because ethnic differences have been reported
for HPA-1. The HPA-1 gene polymorphism was identiﬁed by polymerase chain
reaction (PCR) method. Distribution of the HPA-1 gene polymorphism alles (allel 1a,
allel 1b) genotypes (1a1a, 1a1b and 1b1b) were determined in study population.
Demographic characteristics and risk factors for AF and stroke were evaluated in the
study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. Genotype and allel distribution of AF patients who have had a stroke
and control groups shown in the table. The frequency of 1a1a genotype of HPA-1
polymorphism was signiﬁcantly lower in patients with AF patients who have had
a stroke group compared with control group (49 (70%) vs 57 (87.7%), p¼0.012). The
frequency of 1a1b genotype heterozygous genotype was signiﬁcantly higher in
AF patients who have had a stroke group than control (18 (25.7%) vs 6 (9.2%),
p¼0.012). Between the two groups were compared according to the dominant
genetic model (1a1b + 1b1b vs. 1a1a), The number of patients carrying at least one 1b
mutant allele (1a1b + 1b1b) was signiﬁcantly higher in AF patients who have
had a stroke group than control (21 (30%) vs 7 (10.8%), p¼0.006). With respect to
allelic distribution (1a vs 1b, additive model), the frequency of the 1b allele was
signiﬁcantly higher in AF patients who have had a stroke (24 (17.1%) vs 8 (6.1%),
p¼0.009).
Conclusıons: In this study, our data suggest that the HPA-1 gene polymorphisms may
be associated with AF patients who have had a stroke from other clinical risk factors,
but this should be conﬁrmed in a much larger series of patients. Screening for this
mutation may help in identifying patients at risk and in deciding the antithrombotic
strategy.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-158
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Objectıve: Prediabetes is a predictor of manifest diabetes mellitus (DM) and is known
to be associated with increased cardiovascular mortality and morbidity. As the diabetic
patients are at higher risk of developing atrial ﬁbrillation (AF), a signiﬁcant part of the
patients with lone AF are also diabetic. Inter-atrial and intra-atrial electromechanical
coupling time which can be measured by both prolonged P wave dispersion and tissue
Doppler imaging are known as the non-invasive predictors of atrial ﬁbrillation.
Impairment of left mechanical functions could be associated with the increased risk of
developing AF. In our study, we examined the atrial electromechanical coupling time
which is measured by the tissue Doppler imaging (TDI), left atrial (LA) mechanical
function by disc method, and P wave dispersion of the prediabetic patients.
Matherıal-Method: 50 prediabetic (22 M, 28 F; median age: 5110 years) and 41
healthy subjects as control group included in this study. Atrial electromechanical
coupling time was calculated from lateral mitral annulus (PA lateral), septal mitral
annulus (PA septum) and right ventricular tricuspid annulus (PA tricuspid) by TDI. Left
atrial volumes (maximum, minimum, and pre-systolic) were measured in the apical
four-chamber view with the disk method and were indexed to body surface area. Left
atrial mechanical functions (LAPEV, LAPEF, LAAEV, LAAEF, CV, LATEV) were
evaluated. P wave dispersion was obtained by 12-lead electrocardiography and was
calculated as subtracting the minimum Pwave duration frommaximumPwave duration
period. The results of prediabetic and control groups were analysed.
Results: Inter-atrial (PA lateral-PA tricuspid) and left atrial electromechanical delays
were found to be signiﬁcantly longer in patients with prediabetes than the control group
(21.510.5 vs 13.85.6 msec; p < 0.001, 12.58.1 vs 6.73.7, p < 0.001, respec-
tively). Maximum and pre-systolic volumes were found to be similar in both groups
(29.17.2 to 27.18.2, p¼0.24, 18.64.4 to 17.86.6, p¼0.14, respectively). In the
prediabetic patients, LATEV, LAAEV, CV and LAAEF were found to be higher than
the control group (18,86,3 vs 16,14,5, p¼0,01; 8,73,1 to 5,72,4; p<0,001,
31,38,3 vs 27,59,7, p¼0,047; 0,530,16 vs 0,310,13, p<0,001, respectively).
In prediabetic patients, P-wave dispersion was found to be longer than the control
group (55,311,1 msec to 28.95.9 msec, p<0.001, respectively).
Conclusıon: Prolonged atrial electromechanical delay and prolonged PWD suggested
that prediabetic population have an increased risk for development of AF than the
normal population. Impaired left atrial mechanical functions could be a predictor of
the heart failure and atrial ﬁbrillation which may develop in future. In our opinion, in
patients with presiabetes, some precautions are to be taken before the development of
overt diabetes, may prevent such cardiovascular complications as AF and heart failure.
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Occurrence and progression of coronary artery disease (CAD) and heart failure
(HF) are accompanied by worsening of autonomic regulation of circulation. In its turn,
this contributes to development of supraventricular arrhythmias. In this connection,
neural activity modulation may be an effective approach to treatment and prevention.
Methods: Estimation of sympathetic and parasympathetic activity in 40 patients with
CAD and paroxysmal atrial ﬁbrillation (AF) and in 40 healthy subjects was performed
by Valsalva maneuver test, evaluation of heart rate variability (HRV) and bloodERS C143
